Alzheimers Dement

1. GEZEGEN H, Alaylioglu M, Sahin E, Swann O, et al
   Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis.
   Alzheimers Dement. 2025;21:e70162.
   

   >> Share

   
   
2. LIAO W, Xuan J, Ryu WI, Bormann MK, et al
   Interconnections of insulin/IGF-1 signaling and autophagy abnormalities in Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70099.
   

   >> Share

   
   
3. FERTAN E, Meisl G, Klenerman D
   Small-diffusible aggregates, plaques, tangles, and dynamic equilibria: Untangling Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70462.
   

   >> Share

   
   
4. FALGAS N, Maure-Blesa L, Ances B, Flores-Aguilar L, et al
   Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference.
   Alzheimers Dement. 2025;21:e70309.
   

   >> Share

   
   
5. RUDOLPH MD, Sutphen CL, Register TC, Lockhart SN, et al
   Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort.
   Alzheimers Dement. 2025;21:e70426.
   

   >> Share

   
   
6. BROWN CA, Das SR, Cousins KAQ, Tropea TF, et al
   Tau burden is best captured by magnitude and extent: Tau-MaX as a measure of global tau.
   Alzheimers Dement. 2025;21:e70346.
   

   >> Share

   
   
7. KANG JW, Khatib LA, Heston MB, Dilmore AH, et al
   Gut microbiome compositional and functional features associate with Alzheimer's disease pathology.
   Alzheimers Dement. 2025;21:e70417.
   

   >> Share

   
   
8. GIMENEZ S, Vaque-Alcazar L, Zhu N, Benejam B, et al
   Impact of Alzheimer's disease on sleep in adults with Down syndrome.
   Alzheimers Dement. 2025;21:e70400.
   

   >> Share

   
   
9. LEMING M, Im H
   Differential dementia detection from multimodal brain images in a real-world dataset.
   Alzheimers Dement. 2025;21:e70362.
   

   >> Share

   
   
10. KEMNA RE, Kueck PJ, Honea R, Clark Z, et al
    Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70390.
    

    >> Share

    
    
11. GALGANI A, Mary A, Lombardo F, Martini N, et al
    Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients.
    Alzheimers Dement. 2025;21:e70434.
    

    >> Share

    
    
12. CARRIGAN M, Bocancea DI, Vogel J, van Loenhoud AC, et al
    A novel approach to resilience and its links with education and Alzheimer's disease genetics.
    Alzheimers Dement. 2025;21:e70379.
    

    >> Share

    
    
13. FU JF, Garimella A, Lapointe A, Aye WWT, et al
    Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairments.
    Alzheimers Dement. 2025;21:e70424.
    

    >> Share

    
    
14. MALOTAUX V, Ashton NJ, Ohrfelt A, Chen Y, et al
    Plasma p-tau231 in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional and longitudinal cohort study.
    Alzheimers Dement. 2025;21:e70421.
    

    >> Share

    
    

    
    Am J Geriatr Psychiatry

15. BONAR EE, Tan CY, Patyk A, Lei L, et al
    Agitation in Alzheimer's Disease as a Qualifying Condition for Medical Cannabis in the United States: A Brief Report on Current Trends.
    Am J Geriatr Psychiatry. 2025 Jun 11:S1064-7481(25)00363.
    

    >> Share

    
    

    
    BMC Geriatr

16. MORGELI R, Borchers F, Feinkohl I, Piper SK, et al
    A secondary analysis of cortical atrophy and plasma amyloid beta patterns in older patients with cognitive frailty undergoing elective surgery.
    BMC Geriatr. 2025;25:484.
    

    >> Share

    
    
17. SU H, Zhu J, Wang Y, Jin J, et al
    Reliability and validity analysis of the Chinese version of the Quick Dementia Rating System (QDRS).
    BMC Geriatr. 2025;25:455.
    

    >> Share

    
    

    
    BMC Neurol

18. LONG Y, Liu J, Guo J, Jiang J, et al
    Integrated genetic analysis of Alzheimer's disease and stroke subtypes: insights from LDSC, PLACO, and MR studies.
    BMC Neurol. 2025;25:260.
    

    >> Share

    
    

    
    Curr Alzheimer Res

19. PLUTA R, Kocki J, Kocka AB, Bogucki J, et al
    Alterations of Mitophagy (BNIP3), Apoptosis (CASP3), and Autophagy (BECN1) Genes in the Frontal Cortex in an Ischemic Model of Alzheimer's Disease with Long-Term Survival.
    Curr Alzheimer Res. 2025 Jul 2. doi: 10.2174/0115672050385480250619045022.
    

    >> Share

    
    

    
    Curr Opin Neurol

20. PAPOULI A, Cole JH
    Brain age prediction from MRI scans in neurodegenerative diseases.
    Curr Opin Neurol. 2025;38:316-321.
    

    >> Share

    
    

    
    Dement Geriatr Cogn Disord

21. SEIXAS-LIMA B, Binns M, Black SE, Freedman M, et al
    The relationship between age and cognitive subtypes of Alzheimer's disease and related dementias.
    Dement Geriatr Cogn Disord. 2025 Jun 30:1-19. doi: 10.1159/000547124.
    

    >> Share

    
    

    
    Exp Neurol

22. FRENCH AR, Christian-Hinman CA
    Aromatase inhibition modulates intrinsic properties and excitability of hippocampal CA1 pyramidal cells in the APP/PS1 mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Jun 30:115365. doi: 10.1016/j.expneurol.2025.115365.
    

    >> Share

    
    

    
    J Alzheimers Dis

23. LIU J, Duangjan C, Phan NM, Curran SP, et al
    Loss of WDR23 slows the rate of age-related cognitive decline with elevated amyloid burden.
    J Alzheimers Dis. 2025;106:218-229.
    

    >> Share

    
    
24. CAI Y, Wang X, Xiang Y, Wang Z, et al
    Codonopsis pilosula polysaccharides alleviate neuronal apoptosis induced by endoplasmic reticulum stress-activated PERK-ATF4-CHOP signaling in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:317-330.
    

    >> Share

    
    
25. ZHAI A, Zou R, Lv T, Yang S, et al
    Genetic association of social participation with cognitive function: A bidirectional Mendelian randomization study.
    J Alzheimers Dis. 2025;106:259-270.
    

    >> Share

    
    
26. ANDERSEN LSN, Simonsen AH, Vogel A, McWilliam OH, et al
    Isolated elevation of 181p-tau in the cerebrospinal fluid is associated with distinct clinical features: Findings from a Danish memory clinic cohort.
    J Alzheimers Dis. 2025;106:111-119.
    

    >> Share

    
    
27. SEKIKAWA A, Higashiyama A, Lopresti BJ, Ihara M, et al
    An inverse association of cerebral amyloid-beta deposition and serum docosahexaenoic acid levels in cognitively normal older adults in Japan.
    J Alzheimers Dis. 2025;106:378-386.
    

    >> Share

    
    
28. YIN A, Gui Y, Wan L, Cai Q, et al
    p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:352-362.
    

    >> Share

    
    
29. HOILUND-CARLSEN PF, Alavi A, Costa T, Neve RL, et al
    Is US residence a risk factor for Alzheimer's disease?
    J Alzheimers Dis. 2025 Jul 3:13872877251356682. doi: 10.1177/13872877251356682.
    

    >> Share

    
    
30. PALEY JL, Scheiffele GD, Li Y, Shaaban CE, et al
    Neighborhood deprivation and mortality among people with Alzheimer's disease and related dementia.
    J Alzheimers Dis. 2025 Jul 2:13872877251352120. doi: 10.1177/13872877251352120.
    

    >> Share

    
    
31. HSU YH, Huang SM, Kuo LW, Yang JJ, et al
    Diagnostic utility of the item-specific Encoding Deficit Index in relation to medial temporal lobe atrophy in early-stage Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 2:13872877251351612. doi: 10.1177/13872877251351612.
    

    >> Share

    
    
32. BOSE C, Hindle A, Smith SC, Strickland J, et al
    Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.
    J Alzheimers Dis. 2025 Jul 1:13872877251352107. doi: 10.1177/13872877251352107.
    

    >> Share

    
    
33. WALCZAK K, Kolodziejczyk W, Pszczolowska M, Kozlowska M, et al
    Klotho protein in Alzheimer's disease: Diet leading to immortality?
    J Alzheimers Dis. 2025 Jul 1:13872877251350125. doi: 10.1177/13872877251350125.
    

    >> Share

    
    
34. LIU SK, Cao H, Yang X, Zhou X, et al
    An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population.
    J Alzheimers Dis. 2025 Jul 1:13872877251350722. doi: 10.1177/13872877251350722.
    

    >> Share

    
    
35. SARAIVA JA, Becker M, Dyrba M, Bolukbas B, et al
    Electroencephalogram features support the retrogenesis hypothesis of Alzheimer's disease: Exploratory comparison of brain changes in aging and childhood.
    J Alzheimers Dis. 2025 Jun 30:13872877251352119. doi: 10.1177/13872877251352119.
    

    >> Share

    
    
36. SATO K, Niimi Y, Ihara R, Iwata A, et al
    Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 30:13872877251350718. doi: 10.1177/13872877251350718.
    

    >> Share

    
    
37. WANG G, Chen T, O'Gorman J, Li Y, et al
    Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials.
    J Alzheimers Dis. 2025 Jun 30:13872877251352189. doi: 10.1177/13872877251352189.
    

    >> Share

    
    
38. SHANG ZT, Huang XY, Xiong LL, Xu ZC, et al
    Methanol extract from miracle fruit seeds mitigates Alzheimer's disease and enhance autophagy via suppressing the AKT/mTOR signal pathway.
    J Alzheimers Dis. 2025 Jun 30:13872877251352545. doi: 10.1177/13872877251352545.
    

    >> Share

    
    
39. ESLICK S, Austin G, Ferguson JJ, Garg ML, et al
    Blood biomarkers of Alzheimer's disease in Australians habitually consuming various plant-based diets.
    J Alzheimers Dis. 2025 Jun 30:13872877251351549. doi: 10.1177/13872877251351549.
    

    >> Share

    
    
40. RICCHI I, Griffa A, Corredor-Jerez R, Richiardi J, et al
    The complementary role of automated brain volumetry to stratify ADNI participants within the ATN framework.
    J Alzheimers Dis. 2025;106:245-258.
    

    >> Share

    
    
41. LOJO-RAMIREZ JA, Fernandez-Rodriguez P, Guerra-Gomez M, Marin-Cabanas AM, et al
    Evaluation of early-phase (18)F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with (18)F-FDG PET at group and single patient level.
    J Alzheimers Dis. 2025;106:304-316.
    

    >> Share

    
    

    
    J Biol Chem

42. KURKELA M, Dvorakova L, Koivisto H, Uusitalo M, et al
    Targeting HIF-P4H-2 in APP/PS1 Alzheimer's mouse model improves glucose metabolism, reduces dystrophic neurites and maintains exploratory activity.
    J Biol Chem. 2025 Jul 1:110432. doi: 10.1016/j.jbc.2025.110432.
    

    >> Share

    
    

    
    J Neurochem

43. CHEN Y, Albert AL, Sehrawat A, Farinas MF, et al
    Equivalence of Plasma and Serum for Clinical Measurement of p-tau217: Comparative Analyses of Four Blood-Based Assays.
    J Neurochem. 2025;169:e70114.
    

    >> Share

    
    
44. HARDY J
    Milestone Review: The History of Molecular Genetics Analysis of Alzheimer's Disease.
    J Neurochem. 2025;169:e70148.
    

    >> Share

    
    

    
    Nat Med

45. COLONNA M, Holtzman DM
    Rethinking TREM2 as a target for Alzheimer's disease after the INVOKE-2 trial failure.
    Nat Med. 2025 Jul 2. doi: 10.1038/s41591-025-03816.
    

    >> Share

    
    

    
    Nat Rev Neurol

46. TADDEI RN, Duff KE
    Synapse vulnerability and resilience across the clinical spectrum of dementias.
    Nat Rev Neurol. 2025;21:353-369.
    

    >> Share

    
    

    
    Neurobiol Aging

47. AKRADI M, Farzane-Daghigh T, Ebneabbasi A, Bi H, et al
    How is self-reported sleep-disordered breathing linked with biomarkers of Alzheimer's disease?
    Neurobiol Aging. 2025;154:16-24.
    

    >> Share

    
    

    
    Neurobiol Dis

48. PELAGOTTI V, Plantone D, D'Amico F, Raffa S, et al
    [(18)F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease.
    Neurobiol Dis. 2025 Jul 1:107014. doi: 10.1016/j.nbd.2025.107014.
    

    >> Share

    
    

    
    Neurol Clin Pract

49. SCHWARTZ NU, Dietz CD, Prufer Araujo I, Villanueva-Meyer JE, et al
    Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease.
    Neurol Clin Pract. 2025;15:e200508.
    

    >> Share

    
    

    
    PLoS Biol

50. CHEN S, Zhou J, Wang S, Chen E, et al
    Gnb5 is a negative regulator of the BACE1-mediated Abeta generation and ameliorates cognitive deficits in a mouse model of Alzheimer's disease.
    PLoS Biol. 2025;23:e3003259.
    

    >> Share

    
    

    
    PLoS One

51. ZHANG J, Huang Y, Jiang Y, Li T, et al
    Knowledge and attitudes towards Alzheimer's disease among adult residents in Jiulongpo, Chongqing, China: A cross-sectional survey.
    PLoS One. 2025;20:e0327346.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share